Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPE pseudogene 6 (SNRPEP6) is a pseudogene of the SNRPE gene, which encodes Small nuclear ribonucleoprotein polypeptide E, a core component of the spliceosome that plays a central role in pre-mRNA processing and 3' end processing of histone transcripts. SNRPEP6 itself does not encode a protein and is not known to have therapeutic relevance as a drug target. Pseudogenes like SNRPEP6 may have regulatory effects through non-coding RNA, such as antisense RNA interactions or microRNA competition, but these functions are not confirmed or characterized for SNRPEP6 specifically. Summary: SNRPE pseudogene 6 is not a molecular target, receptor, or functional protein, but a genomic pseudogene related to the SNRPE gene; it does not possess druggability or canonical biological functions and should not be considered a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNRPE pseudogene 6 (SNRPEP6).